Back to today’s briefing

Story perspectives

J&J Reaches $5.5 B Settlement in Talc Cancer Cases

7/28/2026

50 10 Full Breakdown

Summary

Story summary

Johnson & Johnson announced a $5.5 billion settlement to resolve lawsuits alleging its talc products caused ovarian cancer.
The settlement covers roughly 76,000 claims and requires 95% acceptance to become final.
Johnson & Johnson will pay $3 billion in 2027 and more in 2028, with total payouts possibly over $7 billion because the settlement does not cap liability.
A federal judge doubted plaintiffs could prove talc caused ovarian cancer.

History

Historical Context

By November 23 1998, the attorneys general of 46 states and the four major tobacco firms—including Philip Morris—signed the Master Settlement Agreement, obligating at least $206 billion in payments and imposing advertising limits. This landmark deal ended a decade of state lawsuits that began in 1994 and created a template for later billion-dollar product-liability settlements.

1 of 2

Story summary

Johnson & Johnson announced a $5.5 billion settlement to resolve lawsuits alleging its talc products caused ovarian cancer.
The settlement covers roughly 76,000 claims and requires 95% acceptance to become final.
Johnson & Johnson will pay $3 billion in 2027 and more in 2028, with total payouts possibly over $7 billion because the settlement does not cap liability.
A federal judge doubted plaintiffs could prove talc caused ovarian cancer.

1 / 2